Dopaminergic cell protection and alleviation of neuropsychiatric disease symptoms by VMAT2 expression through the class I HDAC inhibitor TC‐H 106

• Main Authors: Heejin Lee (Author), Hye‐Ji Kim (Author), Dong‐Kyu Choi (Author), Eu n.‐A. Ko (Author), Jae‐Hyeog Choi (Author), Yohan Seo (Author), Sion Lee (Author), Soong‐Hyun Kim (Author), Sejin Jung (Author), Minwoo Kim (Author), Dongwan Kang (Author), Chun‐Young Im (Author), Gi‐Hun Bae (Author), Sung‐Cherl Jung (Author), Oh‐Bin Kwon (Author)
• Format: Book
• Published: Wiley, 2023-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract The importance of vesicular monoamine transporter 2 (VMAT2) in dopamine regulation, which is considered crucial for neuropsychiatric disorders, is currently being studied. Moreover, the development of disease treatments using histone deacetylase (HDAC) inhibitors (HDACi) is actively progres...